Ethinylestradiol/levonorgestrel - Nobelpharma

Drug Profile

Ethinylestradiol/levonorgestrel - Nobelpharma

Alternative Names: NPC-16

Latest Information Update: 09 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nobelpharma
  • Class Alkylated estrogenic steroids; Contraceptives; Hormonal replacements; Norpregnanes; Norpregnatrienes; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Female genital diseases

Most Recent Events

  • 08 Sep 2017 Phase III development in Gynaecological disorders is ongoing in Japan
  • 19 Feb 2015 Nobelpharma plans a phase III trial for Dysmenorrhoea in Japan (NCT02362711)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top